These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4118107)

  • 1. Effects of plasmin on human factor VIII (AHF).
    Pasquini R; Hershgold EJ
    Blood; 1973 Jan; 41(1):105-11. PubMed ID: 4118107
    [No Abstract]   [Full Text] [Related]  

  • 2. Degradation of bovine factor 8 by plasmin and trypsin.
    Kirby EP; Martin N; Marder VJ
    Blood; 1974 May; 43(5):629-40. PubMed ID: 4274479
    [No Abstract]   [Full Text] [Related]  

  • 3. The structure of the fibrinogen degradation products.
    Marder VJ; Budzynski AZ
    Prog Hemost Thromb; 1974; 2(0):141-74. PubMed ID: 4137300
    [No Abstract]   [Full Text] [Related]  

  • 4. Elevated antihemophilic factor (AHF, factor VIII) procoagulant activity and AHF-like antigen in alcoholic cirrhosis of the liver.
    Green AJ; Ratnoff OD
    J Lab Clin Med; 1974 Feb; 83(2):189-97. PubMed ID: 4204243
    [No Abstract]   [Full Text] [Related]  

  • 5. Neoantigenic expressions engendered by plasmin cleavage of fibrinogen.
    Plow EF; Hougie C; Edgington TS
    J Immunol; 1971 Nov; 107(5):1496-500. PubMed ID: 4107365
    [No Abstract]   [Full Text] [Related]  

  • 6. Degradation of fibrinogen in vitro. Demonstration of several antigenic intermediates by specific anti-D and anti-E serum.
    Gormsen J; Feddersen C; Clemmensen I; Andersen RB
    Scand J Haematol; 1972; 9(6):577-86. PubMed ID: 4118846
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification and purification of fibrinogen degradation products produced by plasmin: considerations on the structure of fibrinogen.
    Marder VJ
    Scand J Haematol Suppl; 1971; 13():21-36. PubMed ID: 4258202
    [No Abstract]   [Full Text] [Related]  

  • 8. The demonstration of plasmin agglutinators in human sera.
    Waller M; Curry N
    Vox Sang; 1970 Jul; 19(1):34-46. PubMed ID: 4249803
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunological characterization of purified anti-haemophilic factor A (factor VIII) which corrects abnormal platelet retention in Von Willebrand's disease.
    Bouma BN; Wiegerinck Y; Sixma JJ; Van Mourik JA; Mochtar IA
    Nat New Biol; 1972 Mar; 236(65):104-6. PubMed ID: 4112547
    [No Abstract]   [Full Text] [Related]  

  • 10. The cold-insoluble globulin of plasma and its relationship to factor VIII.
    Cooper HA; Wagner RH; Mosesson MW
    J Lab Clin Med; 1974 Aug; 84(2):258-63. PubMed ID: 4135593
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasmin digestion of factor VIII: characterization of the breakdown products with respect to antigenicity and von Willebrand activity.
    Guisasola JA; Cockburn CG; Hardisty RM
    Thromb Haemost; 1978 Oct; 40(2):302-15. PubMed ID: 153594
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of human platelet aggregation by plasmin digests of human factor VIII.
    Donati MB; de Gaetano G; Vermylen J; Verstraete M
    Blood; 1973 Nov; 42(5):749-51. PubMed ID: 4270477
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo and in vitro effects of thrombin and plasmin on human factor VIII (AHF).
    Lian EC; Nunez RL; Harkness DR
    Am J Hematol; 1976; 1(4):481-91. PubMed ID: 137671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Support of ristocetin-induced platelet aggregation by procoagulant-inactive and plasmin-cleaved forms of human factor VIII/von Willebrand factor.
    Andersen JC; Switzer ME; McKee PA
    Blood; 1980 Jan; 55(1):101-8. PubMed ID: 6444272
    [No Abstract]   [Full Text] [Related]  

  • 15. Albumin and coagulation factor 8 (AHF).
    Barrow ES; Graham JB
    Am J Physiol; 1974 Aug; 227(2):412-9. PubMed ID: 4211783
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular structural studies of human factor VIII.
    McKee PA; Andersen JC; Switzer ME
    Ann N Y Acad Sci; 1975 Jan; 240():8-33. PubMed ID: 122889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the nature of antihemophilic factor (factor VIII). Further evidence relating the AHF-like antigens in normal and hemophilic plasmas.
    Bennett B; Forman WB; Ratnoff OD
    J Clin Invest; 1973 Sep; 52(9):2191-7. PubMed ID: 4199413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FURTHER STUDIES ON THE PURIFICATION AND CHARACTERIZATION OF HUMAN PLASMINOGEN AND PLASMIN.
    ROBBINS KC; SUMMARIA L; ELWYN D; BARLOW GH
    J Biol Chem; 1965 Jan; 240():541-50. PubMed ID: 14253466
    [No Abstract]   [Full Text] [Related]  

  • 19. Platelet fibrinogen. Identity and initial observations on the mode of its degradation by plasmin.
    James HL; Bradford HR; Ganguly P
    Biochim Biophys Acta; 1975 Mar; 386(1):209-20. PubMed ID: 236019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of human platelet aggregation by plasmin digests of human and bovine fibrinogen preparations: role of contaminating factor VIII-related material.
    Culasso DE; Donati MB; de Gaetano G; Vermylen J; Verstraete M
    Blood; 1974 Aug; 44(2):169-75. PubMed ID: 4277539
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.